Recurrent massive myxoid liposarcoma in retroperitoneum 10 years post initial operation.

follow‐up liposarcoma myxoid liposarcoma recurrent tumor soft tissue tumors

Journal

IJU case reports
ISSN: 2577-171X
Titre abrégé: IJU Case Rep
Pays: Australia
ID NLM: 101764958

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 03 06 2019
accepted: 27 07 2019
entrez: 4 8 2020
pubmed: 4 8 2020
medline: 4 8 2020
Statut: epublish

Résumé

Myxoid liposarcoma tends to be a relatively good prognosis. Follow-up is recommended once a year from the 5th year after surgery. A 48-year-old man had a massive retroperitoneal tumor, measuring approximately 20 cm. Resection of a huge myxoid liposarcoma had been performed on his back 10 years ago and the weight of the mass was 14 kg. The tumor was resected from the right kidney and its weight was 3.6 kg. Pathological examination showed myxoid liposarcoma and therefore, the tumor was diagnosed as recurrent. But after the resection, no recurrence or metastasis was observed. To our knowledge, the case presents the first report where both initial and recurrent tumors were massive and the time for recurrence was 10 years. Therefore, a follow-up of myxoid liposarcoma might have to be done cautiously throughout the patient's life.

Identifiants

pubmed: 32743442
doi: 10.1002/iju5.12115
pii: IJU512115
pmc: PMC7292138
doi:

Types de publication

Case Reports

Langues

eng

Pagination

296-298

Informations de copyright

© 2019 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Br J Surg. 2005 Feb;92(2):246-52
pubmed: 15505870
Ann Surg Oncol. 2007 Apr;14(4):1507-14
pubmed: 17252290
Cancer. 2007 Jun 15;109(12):2522-31
pubmed: 17510918
Surg Oncol Clin N Am. 2016 Oct;25(4):761-73
pubmed: 27591497
Sarcoma. 2011;2011:538085
pubmed: 22190864
Orthop Traumatol Surg Res. 2015 Feb;101(1):103-7
pubmed: 25583234
Ann Surg. 2006 Sep;244(3):381-91
pubmed: 16926564
Ann Oncol. 2014 Sep;25 Suppl 3:iii102-12
pubmed: 25210080
Sarcoma. 2012;2012:345161
pubmed: 22550416
Clin Orthop Relat Res. 2010 Nov;468(11):3041-6
pubmed: 20499293

Auteurs

Takamasa Horiuchi (T)

Department of Urology The University of Tokyo Tokyo Japan.
Department of Urology Misato Central General Hospital Saitama Japan.

Shigekatsu Maekawa (S)

Department of Urology The University of Tokyo Tokyo Japan.
Department of Urology Iwate Medical University Iwate Japan.

Wataru Obara (W)

Department of Urology Iwate Medical University Iwate Japan.

Haruki Kume (H)

Department of Urology The University of Tokyo Tokyo Japan.

Naoki Matsuoka (N)

Department of Urology Misato Central General Hospital Saitama Japan.

Classifications MeSH